P.T. CONTRIBUTOR INTERVIEW PHILIPPE TRAINAR Head of the SCOR Corporate Foundation for Science WHAT IMPACT DOES THIS RESEARCH HAVE ON THE WORK DONE BY SCOR? P.T. It’s important to keep in mind that the research projects backed by the SCOR Foundation are interested in long-term risk trends and impacts. The outcomes of this research might not necessarily have business impacts here and now, but they are crucial to our understanding of these risks across longer time horizons. This helps SCOR develop a sound long-term and scientifically backed strategic approach to various types of risks. HOW DOES THE FOUNDATION’S WORK CONTRIBUTE TO THE BROADER SCIENTIFIC COMMUNITY? P.T. The research projects we support bring new insights on pressing questions around climate change, human health and long-term care, demographic trends, economy and finance, and actuarial science. By fostering strong partnerships, the SCOR Foundation advances scientific knowledge and promotes best practices in risk management, benefiting both SCOR and the entire industry. However, these topics have implications far beyond the reinsurance industry and we help researchers share their findings widely through workshops, conferences, and webinars. CAN YOU DISCUSS ANY UPCOMING INITIATIVES OR FOCUS AREAS FOR THE FOUNDATION IN THE NEXT FEW YEARS? P.T. We will continue to focus on key risks around geopolitics, pandemics and epidemics, artificial intelligence, longevity, and climate change consequences. We’re particularly interested in exploring the intersection of AI and actuarial science, which could offer insights into enhancing internal modeling while addressing questions around the ethics and limitations of the systematic implementation of AI. the role of auto-antibodies in respiratory pandemics and their genetic foundations. With the support of the SCOR Foundation, the second iteration of this research project was launched in 2024 and will run through 2027. The Foundation’s support for this project exemplifies the spirit of partnership, requiring close collaboration between the Foundation and the research team. The Foundation provides funding and resources, while the researchers bring their expertise and innovative approaches to the study of auto-antibodies. Beyond this, the Foundation remains very involved throughout the project’s lifecycle, through regular updates, interim reports, and steering committee meetings. This ongoing involvement ensures that the research stays on track, aligns with the Foundation’s goals, and that the research is both scientifically rigorous and practically relevant. . Learn more at foundation.scor.com. €14.5M+ devoted to promoting scientific research since 2011 TRANSFORMING TOMORROW WITH OUR VISION 33
RkJQdWJsaXNoZXIy NTkwMzk=